Last Posted: Mar-28-2023 06:33:20
Determinants of COVID-19 vaccine fatigue.
Tanja A Stamm et al. Nature medicine 2023 3
Rare Primary Immunodeficiency Diseases and COVID-19: Evolving Insights and Implications for Clinical and Public Health Practice
E Drzymalla et al, CDC Blog Post, March 27, 2023
Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis.
Deborah Cromer et al. Nature communications 2023 3 (1) 1633
People who catch Omicron are less likely to get Long Covid Vaccination, virus biology may be driving down risk
J Couzin-Frankel, Science, March 2023
Majumder Saikat, et al. Indian journal of medical microbiology 2023 0 0. 12-16
Impact of public health and social measures on contact dynamics during a SARS-CoV-2 Omicron variant outbreak in Quanzhou, China, March to April 2022.
Guo Yichao, et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2023 0 0.
SARSCoV2 Omicron (B. 1.1. 529) recent updates and challenges worldwide.
Das Rina, et al. Infectious disorders drug targets 2023 0 0.
Corrigendum: Elevated IFNA1 and suppressed IL12p40 associated with persistent hyperinflammation in COVID-19 pneumonia.
Jeon Kyeongseok, et al. Frontiers in immunology 2023 0 0. 1175767
Editorial: SARS-COV-2 infections within inborn errors of immunity populations.
Hanitsch Leif Gunnar, et al. Frontiers in immunology 2023 0 0. 1164045
IgG3 Antibody Response to COVID-19 Vaccination in a Patient With a Large Heavy Chain Deletion.
Sarkaria Sandeep, et al. Therapeutic advances in allergy and rhinology 2023 0 0. 27534030231156206
About COVID-19 GPH
Wei Yu, et al. COVID-19 GPH: tracking the contribution of genomics and precision health to the COVID-19 pandemic response. BMC Infectious Diseases (2022) 22:402.
Sign up Email Alert
In PHGKB Databases
Genomics Precision Health (GPH): The use of pathogen and human genomics and advanced molecular detection methods in discovery, clinical and public health investigations and response to COVID-19.
Non Genomics Precision Health (non-GPH): The use of big data, data science, digital health, machine learning and predictive analytic methods (not involving genomics) in discovery, clinical and public health investigations and response to COVID-19
Following categories are annotated by LitCovid from NCBI NIH.
|Mechanism||Underlying cause(s) of covid-19 infections and transmission & possible drug mechanism of action|
|Transmission||Characteristics and modes of covid-19 transmissions, such as human-to-human|
|Diagnosis||Disease assessment through symptoms, test results, and radiological features|
|Prevention||Prevention, control, response and management strategies|
|Case Report||Descriptions of specific patient cases|
|Forecasting||Modelling and estimating the trend of covid-19 spread|
|Health Equity||Relevant to health equity. Search terms are derived from a list provided by the Association for Territorial Health Officials which include terms such as diversity, health disparities, and others.|
|Vaccine||Relevant to vaccine development, evaluation, implementation and impact. For additional information on vaccines and COVID-19. Check out general CDC Information pages|
|Variant||Relevant to SARS-CoV-2 variants and their impact on public health. For additional information on variants COVID-19. Check out CDC New Variants of the Virus that Causes COVID-19 page|
|Surveillance||Relevant to SARS-CoV-2 public health surveillance and tracking. For additional information on COVID-19 surveillance, check out CDC COVID-19 Data Tracker|
Wei Yu, Emily Drzymalla, Marta Gwinn and Muin J. Khoury. COVID-19 GPH: tracking the contribution of genomics and precision health to the COVID-19 pandemic response. BMC Infectious Diseases (2022) 22:402.
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Genomics and Precision Public Health to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 28, 2023
- Content source: